Summit Therapeutics Inc. (SMMT) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Summit Therapeutics Inc. (SMMT) Bundle
Evaluate Summit Therapeutics Inc.'s (SMMT) financial outlook like an expert! This (SMMT) DCF Calculator provides pre-filled financial data while allowing you the freedom to modify assumptions such as revenue growth, WACC, margins, and more to align with your predictions.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .8 | 1.1 | 2.3 | .9 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 36.07 | 110.35 | -61.07 | -100 | -6.25 | -6.25 | -6.25 | -6.25 | -6.25 |
| EBITDA | -21.1 | -46.7 | -78.9 | -66.2 | 1.3 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -2657.39 | -4317.95 | -3467.99 | -7472.75 | 100 | -60 | -60 | -60 | -60 | -60 |
| Depreciation | 1.8 | 2.5 | 3.1 | 3.2 | 114.2 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 220.24 | 232.91 | 135.71 | 356.95 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -22.9 | -49.2 | -82.0 | -69.4 | -112.9 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -2877.63 | -4550.85 | -3603.7 | -7829.7 | 100 | -60 | -60 | -60 | -60 | -60 |
| Total Cash | 62.9 | 83.6 | 90.3 | 438.7 | 234.4 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 6.7 | 12.8 | 1.8 | .4 | 1.1 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 837.59 | 1184.53 | 80.93 | 49.55 | 100 | 86.1 | 86.1 | 86.1 | 86.1 | 86.1 |
| Inventories | .0 | -14.7 | 9.0 | 379.4 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0.000246828483 | -1361.63 | 395.85 | 42809.33 | 100 | 40 | 40 | 40 | 40 | 40 |
| Accounts Payable | 3.3 | 7.7 | 5.5 | .4 | 3.4 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 415.98 | 713.95 | 241.79 | 50.41 | 100 | 90.08 | 90.08 | 90.08 | 90.08 | 90.08 |
| Capital Expenditure | -.3 | -.5 | -.4 | -.8 | -.2 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -41.98 | -48.95 | -16.92 | -88.6 | 100 | -39.29 | -39.29 | -39.29 | -39.29 | -39.29 |
| Tax Rate, % | 0.1536 | 0.1536 | 0.1536 | 0.1536 | 0.1536 | 0.1536 | 0.1536 | 0.1536 | 0.1536 | 0.1536 |
| EBITAT | -19.2 | -49.1 | -79.8 | -65.5 | -112.7 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -21.2 | -34.1 | -92.0 | -437.2 | 383.0 | -2.3 | .0 | .0 | .0 | .0 |
| WACC, % | 5.48 | 5.51 | 5.51 | 5.5 | 5.51 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -2.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | 44 | |||||||||
| Equity Value | -46 | |||||||||
| Diluted Shares Outstanding, MM | 620 | |||||||||
| Equity Value Per Share | -0.07 |
What You Will Get
- Real SMMT Financial Data: Pre-filled with Summit Therapeutics’ historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Summit Therapeutics’ intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Clinical Data: Access reliable pre-loaded historical performance metrics and future clinical projections.
- Customizable Assumptions: Modify highlighted cells for variables such as R&D expenses, market growth rates, and profit margins.
- Automated Financial Analysis: Instant updates to DCF, Net Present Value (NPV), and revenue forecasts.
- User-Friendly Dashboard: Intuitive charts and summaries to easily interpret your financial assessments.
- Designed for All Users: A straightforward, user-centric layout suitable for investors, analysts, and industry professionals.
How It Works
- Download the Template: Gain immediate access to the Excel-based SMMT DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, profit margins, and more.
- Instant Calculations: The model automatically recalculates Summit Therapeutics' intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator for Summit Therapeutics Inc. (SMMT)?
- Designed for Experts: A sophisticated tool favored by analysts, investors, and healthcare consultants.
- Comprehensive Data: Summit Therapeutics' historical and projected financials preloaded for precise analysis.
- Scenario Analysis: Effortlessly test various forecasts and assumptions to gauge potential outcomes.
- Transparent Results: Automatically computes intrinsic value, NPV, and essential metrics for informed decision-making.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the calculation process.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for analyzing Summit Therapeutics Inc. (SMMT).
- Pharmaceutical Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Summit Therapeutics Inc. (SMMT).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling related to biotech firms.
- Biotech Enthusiasts: Gain insights into how companies like Summit Therapeutics Inc. (SMMT) are valued in the healthcare market.
What the Summit Therapeutics Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Summit Therapeutics Inc. (SMMT).
- Real-World Data: Summit Therapeutics’ historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to Summit Therapeutics Inc. (SMMT).
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for informed decision-making.